ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Protokinetix Inc (PK)

Protokinetix Inc (PK) (PKTX)

0.0082
-0.0003
( -3.53% )
Updated: 14:56:50

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0082
Bid
0.0084
Ask
0.011
Volume
50,000
0.0082 Day's Range 0.0082
0.008 52 Week Range 0.0199
Market Cap
Previous Close
0.0085
Open
0.0082
Last Trade
20000
@
0.0082
Last Trade Time
13:44:56
Financial Volume
$ 410
VWAP
0.0082
Average Volume (3m)
151,094
Shares Outstanding
366,980,152
Dividend Yield
-
PE Ratio
-9.09
Earnings Per Share (EPS)
-0
Revenue
-
Net Profit
-415k

About Protokinetix Inc (PK)

ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a m... ProtoKinetix is a research and development company leading the way in cell survival solutions. AAGP, our patented anti-aging glycopeptide, is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide keeps more cells alive longer. It utilizes the same properties that help animals survive in arctic temperatures, and it has the capability to change regenerative medicine forever. Show more

Sector
Business Services, Nec
Industry
Pharmaceutical Preparations
Headquarters
Las Vegas, Nevada, USA
Founded
1999
Protokinetix Inc (PK) is listed in the Business Services sector of the OTCMarkets with ticker PKTX. The last closing price for Protokinetix (PK) was $0.01. Over the last year, Protokinetix (PK) shares have traded in a share price range of $ 0.008 to $ 0.0199.

Protokinetix (PK) currently has 366,980,152 shares outstanding. The market capitalization of Protokinetix (PK) is $3.12 million. Protokinetix (PK) has a price to earnings ratio (PE ratio) of -9.09.

PKTX Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.00625-43.25259515570.014450.01490.0082527710.00981969CS
4-0.0028-25.45454545450.0110.01490.00821544480.0121765CS
12-0.00162-16.49694501020.009820.01490.0081510940.01110022CS
26-0.0035-29.91452991450.01170.01490.0081389670.01048339CS
52-0.007-46.05263157890.01520.01990.0081209320.01178658CS
156-0.0688-89.35064935060.0770.0820.0081046720.02340236CS
260-0.1918-95.90.20.270.008900610.0601991CS

PKTX - Frequently Asked Questions (FAQ)

What is the current Protokinetix (PK) share price?
The current share price of Protokinetix (PK) is $ 0.0082
How many Protokinetix (PK) shares are in issue?
Protokinetix (PK) has 366,980,152 shares in issue
What is the market cap of Protokinetix (PK)?
The market capitalisation of Protokinetix (PK) is USD 3.12M
What is the 1 year trading range for Protokinetix (PK) share price?
Protokinetix (PK) has traded in the range of $ 0.008 to $ 0.0199 during the past year
What is the PE ratio of Protokinetix (PK)?
The price to earnings ratio of Protokinetix (PK) is -9.09
What is the reporting currency for Protokinetix (PK)?
Protokinetix (PK) reports financial results in USD
What is the latest annual profit for Protokinetix (PK)?
The latest annual profit of Protokinetix (PK) is USD -415k
What is the registered address of Protokinetix (PK)?
The registered address for Protokinetix (PK) is 606 S NINTH ST, LAS VEGAS, NEVADA, 89101 7013
What is the Protokinetix (PK) website address?
The website address for Protokinetix (PK) is www.protokinetix.com
Which industry sector does Protokinetix (PK) operate in?
Protokinetix (PK) operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STTOSITO Mobile Ltd (CE)
$ 0.17
(84,900.00%)
278
SHMPNaturalShrimp Incorporated (CE)
$ 0.0005
(49,900.00%)
482.17k
ASTOAstro Communications Inc (PK)
$ 2.08
(20,494.06%)
1.66k
MRNJMetatron Inc (PK)
$ 0.0001
(9,900.00%)
550k
FBCDFBC Holding Inc (PK)
$ 0.0001
(9,900.00%)
600k
SHWZMedicine Man Technologies Inc (CE)
$ 0.000001
(-99.99%)
450
NEPTFNeptune Wellness Solutions Inc (CE)
$ 0.000001
(-99.90%)
30k
SYEVSeychelle Environmental Technologies Inc (CE)
$ 0.000001
(-99.83%)
3k
CRFUCarefree Group Inc (CE)
$ 0.0001
(-99.33%)
85.23k
ALFIQALFI Inc (CE)
$ 0.000001
(-99.00%)
450
TMSHTransGlobal Assets Inc (PK)
$ 0.0002
(0.00%)
412.08M
HMBLHUMBL Inc (PK)
$ 0.0003
(-25.00%)
296.38M
RONNRonn Motor Group Inc (PK)
$ 0.0001
(-50.00%)
156.35M
DPLSDarkPulse Inc (PK)
$ 0.0006
(-14.29%)
97.99M
VGLSVG Life Sciences Inc (PK)
$ 0.0001
(0.00%)
91.81M

PKTX Discussion

View Posts
disgusted investor disgusted investor 22 hours ago
unfortunately, so much for that outlook
👍️0
disgusted investor disgusted investor 4 days ago
kind of a disappointing week for this stock. There was a ton of volume.
👍 1
disgusted investor disgusted investor 6 days ago
I recall thinking that was misleading, especially the headline. The stem cells restored the vision . The AAGP help the stem cells survive.
👍 1
SPORT19 SPORT19 6 days ago
https://www.protokinetix.com/protokinetix-aagp-restores-vision-in-blind-test-subjects/
👍 1
disgusted investor disgusted investor 6 days ago
I don't recall it curing blindness in mice, but it helped the cells implanted in the eyes thrive instead of disappointing the researchers
👍️0
SPORT19 SPORT19 6 days ago
Huge potential...already clinically tested and safe on humans...cured blindness in mice...
👍️0
Past and present Past and present 1 week ago
***PKTX..
Stem Cell Therapy Reverses Diabetes..***

According to a new study published in Science Advances, researchers have developed a novel cell transplantation technique that successfully reversed type 1 diabetes in mice, using human islets vascularized with adaptable endothelial cells for functional subcutaneous engraftment.

Breakthrough in Islet Transplantation
The innovative technique employs human reprogrammed vascular endothelial cells (R-VECs) to functionally vascularize pancreatic islets, addressing a major challenge in islet transplantation therapy1. This approach enables:

In vitro functional vascularization of islets with responsive glucose-stimulated insulin secretion

Successful reversal of hyperglycemia in diabetic mice through subcutaneous transplantation

High levels of human insulin in recipient serum, with hyperglycemia returning upon graft removal

R-VECs, engineered by transiently expressing the vascular-specific transcription factor ETV2, demonstrate remarkable adaptability by self-assembling into perfusable vascular networks and acquiring islet endothelial cell-specific characteristics when cocultured with human islets12. This breakthrough represents a significant step towards improved islet transplantation therapy, potentially offering a path to long-term insulin independence for type 1 diabetes patients34.

ncbi.nlm.nih.gov favicon
science.org favicon
pubmed.ncbi.nlm.nih.gov favicon
4 sources
Role of R-VECs in Vascularization
Microenvironmental determinants of endothelial cell ...
Reprogrammed vascular endothelial cells (R-VECs) play a crucial role in enhancing islet transplantation outcomes by providing robust vascularization. Their unique properties and adaptability make them particularly effective for supporting islet survival and function:

R-VECs form extensive vascular networks that arborize and penetrate islets, mimicking native pancreatic vasculature12

When co-cultured with islets, R-VECs acquire islet endothelial cell-specific characteristics, demonstrating remarkable adaptability34

R-VEC-formed blood vessels have larger diameters (13.5 ± 7.5 µm) compared to native human islet capillaries (6.8 ± 2.1 µm), potentially improving blood flow1

Cotransplanted R-VECs contribute substantially more to islet vascularization than host endothelial cells in subcutaneous transplants1

The vascular network formed by R-VECs successfully anastomoses with host circulation, ensuring long-term graft survival31

This advanced vascularization technique addresses a major challenge in islet transplantation, potentially improving graft survival and function while enabling transplantation in more accessible sites like the subcutaneous space.

pubmed.ncbi.nlm.nih.gov favicon
ncbi.nlm.nih.gov favicon
4 sources
Subcutaneous Transplantation Success
Subcutaneous transplantation of vascularized islets marks a significant advancement in type 1 diabetes treatment. This site offers several advantages, including a large surface area, easy accessibility for transplantation and monitoring, and potential graft retrieval if necessary1. Previous attempts at subcutaneous islet transplantation had failed due to insufficient vascularization, but the use of R-VECs overcomes this challenge by forming blood vessels that arborize and vascularize the islets, effectively connecting with the host circulation23.

Transplanted R-VECs form functional blood vessels that support islet survival

Subcutaneous site allows for non-invasive monitoring and potential graft removal

Successful reversal of hyperglycemia in diabetic mice demonstrates the technique's efficacy12

ncbi.nlm.nih.gov favicon
science.org favicon
3 sources
Implications for Type 1 Diabetes
This innovative approach addresses several key challenges in islet transplantation therapy, including the scarcity of donor organs and islet loss due to disconnection from extracellular matrix and vasculature during isolation1. By enabling effective vascularization, the technique potentially reduces inflammatory and rejection reactions that compromise islet survival1. Importantly, this method may pave the way for transplantation without the need for lifelong immunosuppression, a significant drawback of conventional approaches2. The success of this technique in animal models represents a promising step towards translating this therapy to human patients, offering hope for a more effective and durable treatment for type 1 diabetes34.
👍 1
Past and present Past and present 1 week ago
https://www.perplexity.ai/page/stem-cell-therapy-reverses-dia-clGsnmywR4ugK
👍️0
BurgerKing82 BurgerKing82 1 week ago
This one may have potential....What is the OS?
👍️0
HyperPirate75 HyperPirate75 1 week ago
Yeah but still very interesting to see a successful therapy using islet transplant to cure diabetes 1, which is making headlines.. And it's making headlines while it was conducted on mices, PKTX study is on human beings, much more impactful
👍 2
disgusted investor disgusted investor 1 week ago
they don't mention anything obvious specifically about AAGP or any companies. though. Could be all sorts of other research involved in islets transplantation.
👍️0
HyperPirate75 HyperPirate75 1 week ago
Look at this guys, this is our time to shine !!!
👍 1
Past and present Past and present 2 weeks ago
***PKTX.. Dearest Ole Sun.. Have a Good Day and go back to sleep.. :+)
👍️ 1
sunspotter sunspotter 2 weeks ago
With volume like today’s so far, how could it fail?
👍️0
disgusted investor disgusted investor 2 weeks ago
it's got to reach .05 first : )
👍️0
GJ1212 GJ1212 2 weeks ago
Company gonna get bought out ...... at $0.05 per share.
👍 1 🚀 1
SPORT19 SPORT19 2 weeks ago
.0142 with nice bid support!

NEWS COMING!!!!!
👍️0
disgusted investor disgusted investor 2 weeks ago
your attitude seems to have changed
👍️0
SPORT19 SPORT19 2 weeks ago
News coming!

Close at or above.015
👍️0
disgusted investor disgusted investor 3 weeks ago
surprised there isn't more insider buying if something is going on that's positive
👍 1
disgusted investor disgusted investor 3 weeks ago
see what happens next week.
👍️0
SPORT19 SPORT19 3 weeks ago
News coming????
Watch for a jump in PPS


👍️0
disgusted investor disgusted investor 3 weeks ago
nice volume and a tiny increase in price
👍️0
disgusted investor disgusted investor 3 weeks ago
no movement in price, but nice volume
👍️0
scoobey-do scoobey-do 4 weeks ago
HyperPirate75, I see you are new to Investor's hub and to PhotoKinetix's board. Welcome to the IHub board. I look forward to your thoughts regarding PhotoKinetix's Islet transplant test.
👍️ 1
HyperPirate75 HyperPirate75 4 weeks ago
Interesting opinion but i think you are wrong, this stock has been manipulated and accumulated for years, if they do end up posting positive data for a study about diabetes 1, the stock will go up. Islet transplant is a very new method to treat diabete 1 and Alberta uni is at the forefront of this new method, if PKTX enables safer and more efficient islet transplant, it will be a big deal
👍️0
GJ1212 GJ1212 4 weeks ago
The share price will never move up. If it ever gets to five cents ..... those who bought millions and millions of shares at one cent or less will dump them all. Then the PPS will collapse again. The only true way for everyone to get something out of this stock is for there to be a negotiated total buyout. (only my opinion)
👍 1
disgusted investor disgusted investor 4 weeks ago
2021 was the last time this stock crossed through both the 50 and 200 day moving averages.
👍️0
disgusted investor disgusted investor 4 weeks ago
I am not selling. When people stop selling, it might move up
👍️0
SPORT19 SPORT19 4 weeks ago
Big volume today....but as you see the PPS doesn't move....
👍️0
Past and present Past and present 1 month ago
***PKTX..If you call almost a million trades low.. :+O
👍 1
disgusted investor disgusted investor 1 month ago
Wow. Very little volume again today
👍️0
Past and present Past and present 1 month ago
***PKTX.. Whatever you say.. Ole Wise One.. :+)
👍️ 1
sunspotter sunspotter 1 month ago
I'm sorry for your loss.
👍️0
disgusted investor disgusted investor 1 month ago
shmp has just about set itself on fire. They had a fire years ago and are worth less now than after the ashes were swept up
👍️0
Past and present Past and present 1 month ago
***PKTX.. Dear "disgusted investor"...I hope your day is going well.. I have a question for you, why do you say "One thing about PKTX" on this MB, But say something totally opposite on another MB..(Natural Shrimp Inc.(SHMP).. About PKTX..???

***(Your Quote).."this stock is worse than my PKTX AAGP stock Protokinetix"..

***disgusted investor.. Don't worry about your comment on that MB(Natural Shrimp Inc.(SHMP)..At least we "Now" know what you are here on PKTX for..

***Have a great day, tell your buddy SPORT19 hello.. :+)
👍️ 1
disgusted investor disgusted investor 1 month ago
plenty of volume
👍️0
disgusted investor disgusted investor 1 month ago
to put around my tomato plants?
😜 1
SPORT19 SPORT19 1 month ago
Why?
👍 1
disgusted investor disgusted investor 1 month ago
bought some more shares
👍️0
disgusted investor disgusted investor 1 month ago
I know I am not selling.
👍️0
disgusted investor disgusted investor 1 month ago
another nice day of volume 310000 2/5/25
👍️0
HyperPirate75 HyperPirate75 2 months ago
2 more months not 3 mb
👍️0
HyperPirate75 HyperPirate75 2 months ago
Lmao they changed the date of completion again, this time we get a precise date the 25th of march, let's see on the 25th if they put 3 more months to the clock
👍 1
SPORT19 SPORT19 2 months ago
This thing is a dog....awful 
👍️0
SPORT19 SPORT19 2 months ago
If there was anything going on the ask would be swallowed up....
This is how they set up the dump....
👍 2
disgusted investor disgusted investor 2 months ago
something must be up with the clinical results to have this trade 400,000 shares to start the day 1/28/25
🤢 1
disgusted investor disgusted investor 2 months ago
got a link to what you are looking at?
👍️0
SPORT19 SPORT19 2 months ago
There is a FAKE bid on the board....
This happens all the time at PKTX....
Big dump coming.....
👍 1
disgusted investor disgusted investor 2 months ago
this is on some sort of streak. Up five days. When is the last time that happened?
👍️0